Back to results
US 11,441,127 B2Granted
Live attenuated Arkansas serotype infectious bronchitis virus vaccine
AssigneeUniversity of Georgia Research Foundation, Inc.
InventorsBrian J. Jordan, Mark W. Jackwood
Life of this patent
Estimating the term…
Abstract
Attenuated isolates of the Arkansas serotype of infectious bronchitis virus (IBV), including the IBV isolate ArkGA p40 deposited at the ATCC under Patent Designation PTA-126834, and compositions thereof are presented. Methods for administering the isolates or compositions as vaccines to the prevent virulent IBV infection in birds of the order Galliformes are also presented.
Claims16
An infectious bronchitis virus (IBV) isolate, wherein the IBV isolate comprises the IBV isolate ArkGA p40 deposited at the ATCC under Patent Designation PTA-126834.
Dependencies are inferred from the claim text.